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Contextual memory formation relies on the induction
of new genes in the hippocampus. A polymorphism
in the promoter of the transcription factor XBP1
was identified as a risk factor for Alzheimer’s disease
and bipolar disorders. XBP1 is a major regulator of
the unfolded protein response (UPR), mediating
adaptation to endoplasmic reticulum (ER) stress.
Using a phenotypic screen, we uncovered an unex-
pected function of XBP1 in cognition and behavior.
Mice lacking XBP1 in the nervous system showed
specific impairment of contextual memory formation
and long-term potentiation (LTP), whereas neuronal
XBP1s overexpression improved performance in
memory tasks. Gene expression analysis revealed
that XBP1 regulates a group of memory-related
genes, highlighting brain-derived neurotrophic fac-
tor (BDNF), a key component in memory consolida-
tion. Overexpression of BDNF in the hippocampus
reversed the XBP1-deficient phenotype. Our study
revealed an unanticipated function of XBP1 in cogni-
tive processes that is apparently unrelated to its role
in ER stress.
INTRODUCTION
The control of protein synthesis and, hence, the induction of
gene expression are key to the formation and maintenance of
long-term memories (Costa-Mattioli et al., 2009). Mice lacking1382 Cell Reports 14, 1382–1394, February 16, 2016 ª2016 The Auththe a and d isoforms of the cyclic AMP (cAMP) response
element-binding protein (CREB) revealed a key role for this tran-
scription factor in long-termmemory storage (Kogan et al., 1997;
Bourtchuladze et al., 1994), corroborated by CREB-mediated
gene expression in response to stimuli leading to long-term
potentiation (LTP) in the hippocampus (Impey et al., 1996). Local
inhibition of protein synthesis through phosphorylation of the
protein translation initiation factor eIF2a, along with consequent
downstream expression of the CREB family member ATF4,
represses long-term synaptic plasticity and memory consolida-
tion (Costa-Mattioli et al., 2009). Although eIF2a phosphorylation
is a hallmark of the endoplasmic reticulum (ER) stress response
through activation of protein kinase RNA-like ER kinase (PERK)
(Hetz, 2012), the engagement of this pathway during learning
and memory is linked to protein kinases not related to protein-
folding stress, including protein kinase R (PKR) and general
control nonderepressible 2 (GCN2) (Costa-Mattioli et al., 2009;
Zhu et al., 2011; Costa-Mattioli et al., 2005). In contrast, in the
context of Alzheimer’s disease, activation of PERK due to pro-
tein-folding stress impairs memory-related functions (Ma et al.,
2013).
The basic region/leucine zipper transcription factor X-box
binding protein-1 (XBP1) is a third member of the CREB family
that binds to CRE (cAMP-responsive element)-like sequences
in target genes containing unfolded protein response elements
(UPRE). Although it is best known as a key regulator of the
UPR downstream of the ER stress sensor IRE1a (Hetz et al.,
2015), XBP1 also drives gene expression programs that are
not directly connected with cellular stress (see examples in Mar-
tinon et al., 2010; Lee et al., 2008; and Rutkowski and Hegde,
2010). IRE1a is a kinase and endonuclease protein that cata-
lyzes the unconventional splicing of Xbp1 mRNA, introducing aors
frameshift that leads to the production of a transcriptionally
active form of XBP1, termed XBP1s (Walter and Ron, 2011).
XBP1s expression is essential for maintaining the function of
specialized secretory cells and tissues (i.e., B cells, exocrine
and endocrine pancreas, and salivary glands) by controlling
the expression of a cluster of genes involved in protein folding,
secretion, lipid biosynthesis, and ER-associated protein degra-
dation (Lee et al., 2003; Acosta-Alvear et al., 2007; Cornejo
et al., 2013).
Alteration to the ER proteostasis network is emerging as a
relevant player in most common neurodegenerative diseases
involving protein misfolding (Oakes and Papa, 2015). Although
extensive reports have described a functional impact of the
unfolded protein response (UPR) on neurodegenerative dis-
eases (Hetz and Mollereau, 2014), its potential physiological
role in higher functions of the brain remains unexplored. Accu-
mulating studies in models of neurodegeneration support the
idea that the contribution of the UPR to the disease process is
complex and highly dependent on the specific signaling branch
affected and the disease context. For example, we have shown
that targeting either XBP1 or ATF4 in spinal cord injury models
diminishes locomotor recovery (Valenzuela et al., 2012), whereas
XBP1 deficiency has no impact on optic nerve injury (Hu et al.,
2012). Unexpectedly, ablating XBP1 expression in models of
amyotrophic lateral sclerosis and Huntington’s disease has pro-
tective effects through the modulation of autophagy (Hetz et al.,
2009; Vidal et al., 2012). In contrast, ATF4 deficiency protects
against the development of amyotrophic lateral sclerosis by
reducing the expression of pro-apoptotic factors such as
CHOP (Matus et al., 2013), whereas it has no impact on Hunting-
ton’s disease progression (Vidal et al., 2012). Conversely, XBP1
expression is irrelevant in prion-related disorders (Hetz et al.,
2008), whereas PERK activity has a pro-degenerative effect,
possibly through an inhibitory modulation of the expression of
synaptic proteins (Moreno et al., 2012). Many other studies
also support a role of the UPR in neurodegeneration in different
model organisms (Hetz and Mollereau, 2014). Likewise, the UPR
is also emerging as a relevant target in other important pathol-
ogies, including cancer, autoimmunity, and metabolic disorders
(Oakes and Papa, 2015; Hetz et al., 2013).
Although extensive studies associate the UPR and XBP1 with
brain diseases, the possible involvement of the pathway in the
normal physiology of the nervous system remains mostly unex-
plored. Interestingly, genomic screens have identified a poly-
morphism in the XBP1 promoter as a risk factor for Alzheimer’s
disease (Liu et al., 2013), bipolar disorder, and schizophrenia in
certain human populations (Kakiuchi et al., 2003, 2004), suggest-
ing that XBP1 may modulate cognitive processes. In support of
this hypothesis, Xbp1 mRNA appears to be upregulated in ani-
mals exposed to enriched environments (Rampon et al., 2000),
and Xbp1 mRNA splicing is activated locally in neurites in
response to brain-derived neurotrophic factor (BDNF) treatment,
enhancing neurite outgrowth in vitro (Hayashi et al., 2007, 2008).
Neuronal function involves different functional aspects of the
secretory pathway, including synthesis and trafficking of various
plasma membrane receptors and ion channels, engagement of
ER calcium signaling, synthesis of membranes, and assembly
of protein complexes. Consequently, it is possible to speculateCell Rthat components of the UPRmight play an important role in brain
function through classical ER stress outputs.
In this study, we have uncovered an unexpected function of
XBP1 in the control of learning and memory that, surprisingly,
is ER stress independent. This activity of XBP1 in the brain is
linked to the transcriptional regulation of BDNF in the hippocam-
pus. This report identifies a physiological role of this UPR
signaling branch in the nervous system, unrelated to its function
as an ER stress-responsive factor.
RESULTS
XBP1 Deficiency in the Nervous System Reduces
Learning and Memory
To explore the possible participation of XBP1 in cognitive, sen-
sory, or motor functions of the CNS, we performed a behavioral
screen on a neural-specific Xbp1 conditional knockout mouse
model (XBP1Nes/) that we previously described (Hetz et al.,
2008) (Figure S1A, upper panel). In earlier studies, we did not
observe any obvious spontaneous motor or behavioral abnor-
malities in these animals, andwe did not detect histological alter-
ations in their brains under normal conditions (Hetz et al., 2008,
2009; Valenzuela et al., 2012; Vidal et al., 2012). However,
mutant animals displayed a specific impairment in the contextual
and cued fear-conditioning tests (Figure 1A; Figures S1A and
S1B), which assesses hippocampus- and amygdala-dependent
memory (Kim et al., 1993).We alsomeasured the learning capac-
ity of XBP1Nes/ animals using the memory flexibility paradigm,
a hippocampus-dependent test related to episodic memory
(Chen et al., 2000). XBP1Nes/ mice required more trials than
control animals to perform the task, indicating significant mem-
ory impairment (Figure 1B). This phenotype occurred in the
absence of alterations in brain cortex-dependent recognition
memory, motor, anxiety, or reflex control, as assessed by novel
object recognition, rotarod, startle response, hot plate tests,
(Figure S1A) or the swimming velocity in the memory flexibility
(Figure S1C).
To further explore the effects of XBP1 on hippocampal synap-
tic function, wemeasured glutamatergic transmission evoked by
Schaffer collaterals’ stimulation and recorded field excitatory
postsynaptic potentials (fEPSPs) in the CA1 region. LTP, a
long-lasting form of synaptic plasticity whose expression relies
on postsynaptic mechanisms (Granger and Nicoll, 2014), was
drastically impaired in XBP1Nes/ animals, as measured after
theta-burst stimulation (TBS) (Figure 1C) or high-frequency stim-
ulation (HFS) (Figure S2A).We observed a significant reduction in
basal synaptic transmission in XBP1Nes/ animals, evaluated by
input-output curves (Figure 1D). Presynaptic fiber volley (FV)
amplitudes—but not fEPSP slopes, a measure of postsynaptic
activity—were significantly reduced in XBP1Nes/ animals (Fig-
ures S2B and S2C). These results are indicative of a decreased
number of presynaptic neurons firing action potentials. Interest-
ingly, the LTP alterations observed in XBP1Nes/ mice were
maintained for up to 3 hr (Figures S2D and S2E), well into the pro-
tein-synthesis-dependent phase of late LTP that is commonly
associated with long-term memory. Thus, ablation of XBP1 in
the nervous system induces multiple functional deficits in hippo-
campal synapses. Taken together, these results indicate thateports 14, 1382–1394, February 16, 2016 ª2016 The Authors 1383
Figure 1. Altered Long-Term Memory and LTP in XBP1 Conditional Knockout Mice
(A) Left panel: representative images of movement traces in time at different stages of the contextual fear-conditioning assay. I, habituation; II, training; and III,
test. Right panel: XBP1Nes/mice and littermate control (XBP1f/f) malemice were tested in the contextual fear-conditioning assay. Percentage of freezing events
during the test was calculated (XBP1f/f, n = 4; XBP1Nes/, n = 6), and statistical analysis was performed using Student’s t test. R.U., relative units.
(B) Animals were trained and tested using the memory flexibility paradigm. The analysis shows the average number of trials to reach criterion in 4 consecutive
days (n = 4 per group). Statistical analysis was performed using Student’s t test.
(C) LTP was induced by TBS (n = 20 slices from three XBP1Nes/mice; 21 slices from 3 XBP1f/f mice). Statistical analysis was performed using two-way ANOVA.
(D) Basal synaptic transmission recorded in hippocampal CA1 area was assessed by input-output curves plotting FV amplitudes against fEPSP slopes. (n = 26
slices from three XBP1Nes/ mice; 36 slices from three XBP1f/f mice). Statistical analysis was performed using two-way ANOVA followed by Bonferroni
post-test).
Data are presented as mean ± SEM. *p < 0.05; ***p < 0.001.
See also Figures S1, S2, and S4.reducing XBP1 expression in the brain impairs learning and
memory-related processes.
Enforced Expression of XBP1s Improves Learning and
Memory
To test whether increasing active XBP1s in the nervous system
alters the learning and memory capacity of mice, we generated
a transgenic mouse model using the prion promoter to drive
expression of the active XBP1s form in neurons (TgXBP1s). These
animals were viable, did not show alterations in Mendelian ratios
at birth, and did not develop any overt phenotypes. Restricted
expression of the transgene to the CNS was confirmed by west-
ern blot and real-time PCR analysis (Figure 2A, left panel; Figures
S3A and S3B). Immunofluorescence staining for XBP1s in the
hippocampus confirmed that the transgene is expressed almost
exclusively in neurons (Figure 2A, right panel). Remarkably,
sustained neuronal expression of XBP1s improved performance1384 Cell Reports 14, 1382–1394, February 16, 2016 ª2016 The Authin the memory flexibility (Figure 2B) and contextual fear-condi-
tioning tests (Figure 2C). Memory flexibility improvement in
transgenicmicewas not related to changes in swimming velocity
(Figure S3C), suggesting normal motor performance. Consistent
with these results, hippocampal slices derived from TgXBP1s
mice showed enhanced LTP compared with wild-type slices
(Figure 2D), which extended to the protein-synthesis-dependent
phase of late LTP (Figures S3D and S3E). In addition, overex-
pression of XBP1s led to increased basal synaptic transmission
determined through input-output measurements (Figure 2E).
Overall, these results indicate that overexpression of XBP1s in
the nervous system improves the basal learning capacity in
mice, associated with improved LTP and synaptic transmission
in the hippocampus.
To rule out possible compensatory effects of manipulating
XBP1 levels during development in the transgenic mice, and to
directly investigate XBP1 function in the hippocampus, weors
Figure 2. Overexpression of XBP1s in Neurons Enhances Long-Term Memory
(A) An XBP1s neuron-specific transgenic mouse strain was generated using the prion promoter to drive its expression in the nervous system (TgXBP1s). Left panel:
XBP1s levels in the hippocampus were analyzed by western blot using b-actin as loading control. Right panel: Expression of XBP1s, NeuN, and glial fibrillary
acidic protein (GFAP) was evaluated in the hippocampus using immunofluorescence analysis. Scale bars, 100 mm.
(B) Learning performance was assessed in TgXBP1s and littermate control non-transgenic (Non-Tg) animals using the memory flexibility test. The analysis shows
the average number of trials to reach criterion in 4 consecutive days (n = 4 per group). Statistical analysis was performed using Student’s t test.
(C) TgXBP1s mice and littermate control (Non-Tg) male mice were tested in the contextual fear-conditioning assay. Percentage of freezing events during the test
was calculated (TgXBP1s, n = 11; and Non-Tg, n = 11), and statistical analysis was performed using Student’s t test.
(D) LTP induced by TBS was measured in hippocampal slices from TgXBP1s and control animals (n = 7 slices from five mice per group). Statistical analysis was
performed using two-way ANOVA. R.U., relative units.
(E) Input-output curves showing the relationship between FV amplitude and fEPSP slope (n = 70 slices from five Non-Tg mice; 36 slices from three TgXBP1s mice).
Statistical analysis was performed using two-way ANOVA followed by Bonferroni post-test.
(F) Three-month-old mice were injected with serotype 6 AAVs to deliver XBP1s-HA (AAV/XBP1s-HA) or empty vector (AAV/MOCK) into the hippocampus using
bilateral stereotaxis. Fourteen days after injection, animals were trained and tested in the memory flexibility test. The analysis shows the average number of trials
to reach criterion in 4 consecutive days (n = 4 per group). Statistical analysis was performed using Student’s t test.
(G) Rats were injected with AAV particles described in (F) into the hippocampus using two different viral titers (13, 13 106 transducing units [TUs]; 103, 13 107
TUs) through bilateral brain stereotaxis. Left panel: representative immunohistochemistry images of injected brains are shown after staining with an anti-HA
antibody. Arrowheads indicate positive HA neurons. Scale bar, 100 mm. Right panel: 14 days post-injection, rats were trained in the oasis maze task and the
percentage of successful trials was recorded over time (1X titer: AAV/MOCK n = 9; AAV/XBP1s-HA n = 10; 10X titer: AAV/MOCK n = 5; AAV/XBP1s-HA n = 5).
Statistical analysis was performed using two-way ANOVA followed by Bonferroni post-test (*p < 0.05; ***p < 0.001).
Data are presented as mean and SEM. *p < 0.05; **p < 0.01; ***p < 0.001.
See also Figures S3 and S4.
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performed bilateral stereotactic injections of adeno-associated
viruses (AAVs) to deliver XBP1s (AAV/XBP1s-HA [hemaggluti-
nin]) or a control vector (AAV/MOCK) into the CA1 hippocampal
region of adult wild-type mice. Two weeks after AAV injection,
mice were tested in the memory flexibility assay. As in TgXBP1s
animals, local expression of XBP1s in the hippocampus resulted
in improved memory flexibility without significant changes in
swimming velocity (see Figures 2F, S4A, and S4B for a global
comparison of all tests).
We further validated these results in a separate rodent model
using a cognitive test that assesses hippocampal-dependent
memory. We bilaterally injected the CA3 hippocampal region of
rats with two different titers of AAV/XBP1s-HA and, 2 weeks after
surgery, evaluated their behavior in the Oasis Maze (Clark et al.,
2005). Rats expressing XBP1s-HA in the hippocampus (Fig-
ure 2G, left panel) showed a significant increase in the percent-
age of successful attempts to find hidden food in the maze
(Figure 2G, right panel). Thus, enforcement of XBP1s expression
in the hippocampus of wild-type animals is sufficient to improve
higher cognitive functions involved in learning and memory
tasks.
XBP1 Regulates BDNF Expression in the Hippocampus
In the ER stress response, XBP1 supports secretory cell func-
tion through the transcriptional control of a cluster of genes
involved in protein folding, quality control, and the secretory
pathway (Lee et al., 2003; Acosta-Alvear et al., 2007); there-
fore, we measured UPR gene expression (Wfs1, Edem1, and
Bip) in the hippocampus of XBP1Nes/ mice. Surprisingly,
no changes were observed in the basal expression of these
canonical ER stress-related genes (Figure 3A). Alternatively,
the learning and memory deficits observed in XBP1Nes/ an-
imals could be explained by compensatory overactivation of
PERK signaling, resulting in eIF2a phosphorylation and ATF4
induction. Thus, we measured markers of translational control
in the hippocampus of XBP1Nes/ mice but did not detect
any alterations in eIF2a phosphorylation or ATF4 expression
(Figure 3B).
Based on the cognitive defects identified in XBP1Nes/ ani-
mals, we evaluated the expression of a panel of 26 known genes
linked to learning and memory (Table 1). Unexpectedly, XBP1
deficiency led to a marked reduction of Bdnf mRNA levels in
the brain of XBP1Nes/ animals (Figure 3C), in addition to amod-
erate decrease in the expression of genes that participate in
neurotransmission and synaptic plasticity, including Kif17 and
Ampa3 (Figure 3C). Other important memory-related genes
were not significantly altered upon deletion of Xbp1 in the brain,
including glutamate receptors, ryanodine receptors, CREB, syn-
taxin 17, and calcineurin, among others (Table 1). These changes
in gene expression were specific to the hippocampus, since they
were not detected in dissected amygdala from XBP1Nes/mice
(Figure 3D). We also confirmed reduced BDNF and KIF17 protein
expression in the hippocampus of XBP1Nes/ animals (Fig-
ure 3E). Consistent with these results, TgXBP1s mice also dis-
played increased levels of BDNF in the hippocampus compared
to littermate control animals (Figure 3F). Finally, we also evalu-
ated the levels of Bdnf mRNA levels in the hippocampus of
mice injectedwith AAV/XBP1s-HA and detected a significant up-1386 Cell Reports 14, 1382–1394, February 16, 2016 ª2016 The Authregulation of Bdnf expression (Figure 3G). Taken together, these
results demonstrate that XBP1 expression increases the levels of
Bdnf in the mouse hippocampus.
XBP1 Transactivates the BDNF Promoter, Enhancing
Learning and Memory Processes
Through a bioinformatic analysis of the proximal 1-kb 50 promoter
region of Bdnf, Kif17, and Ampa3, we identified a putative
consensus binding site for XBP1 in BDNF promoter IV (Figure 4A,
upper panel) and in the proximal promoter region of Kif17 (data
not shown). Since BDNF is a master regulator of neuronal plas-
ticity and memory-related processes (Park and Poo, 2013), we
focused our analysis on the relationship between XBP1 expres-
sion and BDNF transcription. The canonical XBP1 binding site
with a UPRE B core (Acosta-Alvear et al., 2007) in the mouse
BDNFpromoter IV is located 108 bp upstreamof the transcription
start site and is conserved in mouse, rats, and humans. To test
whether XBP1s transactivates the BDNF promoter, we generated
a luciferase reporter construct including the promoter region
from 604 to +53 bp (Figure 4A, upper panel). Transient co-
expression of XBP1s led to enhanced activity of the BDNF pro-
moter in HEK293T cells (Figure 4A, lower panel). To functionally
validate the identified UPRE B site, we deleted its core ACGT re-
gion (DBNDF-LUC) and tested XBP1s-mediated transactivation.
This mutation fully ablated the ability of XBP1s to activate the
BDNF promoter construct (Figure 4A, lower panel). Finally, using
chromatin immunoprecipitation (ChIP) in the neuronal cell line
Neuro2a transiently transfected with an XBP1s-HA expression
vector, we confirmed the physical interaction between XBP1s
and the UPRE B site in the BDNF promoter (Figure 4B). Impor-
tantly, the binding of XBP1s-HA to the BDNF promoter was com-
parable to its binding to the Dgat2 promoter (Figure 4B), a well-
known XBP1s-target gene (Lee et al., 2008). We also confirmed
a positive binding of XBP1s to the BDNF promoter at basal levels,
usingChiP in hippocampus extracts ofwild-typemice (Figure 4C).
Thus, XBP1s drives changes in hippocampal gene expression
that are not associated with a classical UPR response but instead
involve transactivation of the BDNF promoter.
To investigate a functional connection between decreased
levels of BDNF and the memory deficits observed in XBP1Nes/
animals, we injected serotype 6 AAVs into the hippocampus of
XBP1Nes/ mice to deliver BDNF-GFP or control vector (Fig-
ure 5A, left panel; Figure S4C) and then performed the memory
flexibility test. Remarkably, local expression of BDNF-GFP was
effective in restoringmemory performance of XBP1Nes/ animals
up to a level comparable with that of control animals without
significant changes in swimming velocity (Figure 5A, right panel;
Figure S4D). This result was confirmed in an independent experi-
mental group of animals pre-trained before AAV/BDNF-GFP
injections that were then re-evaluated 2 weeks post-injection (Fig-
ure 5B). Importantly, BDNF overexpression did not alter the per-
formance of control animals, suggesting that the expression levels
of BDNF obtained in our experimental setting are not sufficient to
enhance basal performance but can restore the deficiency
observed in XBP1Nes/ animals. Moreover, exogenous BDNF
also restored hippocampal synaptic transmission, measured as
LTP in XBP1Nes/ mice pre-injected with AAV/BDNF-GFP (Fig-
ure 5C). The recovery of synaptic connectivity was also confirmedors
Figure 3. XBP1 Regulates the Expression of BDNF and a Group of Memory-Related Genes in the Hippocampus
(A) The mRNA levels of indicated UPR-target genes were measured in dissected hippocampus from XBP1Nes/mice or littermate XBP1f/f control animals using
real-time PCR. The analysis was performed at 6 months of age (n = 3 for Xbp1D—deleted Xbp1 mRNA—and n = 5 for Wfs1, Edem, and Bip).
(B) Upper panel: phosphorylated eIF2a (peIF2a) and ATF4 protein levels were measured in dissected hippocampus from XBP1Nes/ mice or littermate XBP1f/f
animals using western blot (n = 3), with Hsp90 and total eIF2a as loading controls. A total lysate from mouse embryonic fibroblasts (MEFs) treated with 5 mg/ml
tunicamycin (Tm) for 16 hr was included as positive control. Lower panel: quantification of peIF2a/eIF2a ratio and ATF4 expression levels after normalization to
Hsp90 expression levels. Statistical analysis was performed using Student’s t test.
(C) The expression levels of several memory-related genes were measured in the hippocampus of XBP1f/f (n = 4) and XBP1Nes/ (n = 5–6) mice using real-time
PCR (see also Table 1 for the complete dataset).
(D) ThemRNA levels ofmemory-related genes indicated in (C) weremeasured in dissected amygdala using real-time PCR. In (A), (C), and (D), averages are shown,
and statistical analysis was performed using Mann-Whitney U test. All samples were normalized to b-actin mRNA levels.
(E) BDNF and KIF17 protein levels were analyzed by western blot, using hippocampus extracts obtained from 6-month-old XBP1f/f and XBP1Nes/ animals.
Levels of b-actin or Hsp90 were used as loading control. Mean and SEM are presented as fold change compared to control animals (n = 3). Bands were spliced
from the same gel under identical film exposure.
(F) BDNF levels were analyzed in dissected hippocampus from TgXBP1s and control mice by western blot (left panel); b-actin was used as loading control. Right
panel: Quantification of BDNF protein levels normalized to b-actin levels (Non-Tg, n = 5; TgXBP1s, n = 7 mice). Statistical analysis was performed using Student’s
t test.
(legend continued on next page)
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Table 1. Gene Expression Profile in the Hippocampus of XBP1Nes/ Animals
Gene
Mean; SEM
p Value Gene DescriptionXBP1f/f XBP1Nes/
Ttr 1; 0.25 0.81; 0.39 0.571 transthyretin
Reln 1; 0.32 0.68; 0.05 0.73 reelin
Gria1 1; 0.16 0.75; 0.11 0.286 glutamate receptor, ionotropic, AMPA1 (alpha1)
Gria2 1; 0.06 0.77; 0.06 0.063 glutamate receptor, ionotropic, AMPA2 (alpha 2)
Gria3a 1; 0.05 0.58; 0.05 0.016 glutamate receptor, ionotropic, AMPA3 (alpha3)
Gria4 1; 0.12 0.93; 0.08 0.113 glutamate receptor, ionotropic, AMPA4 (alpha4)
Myo5b 1; 0.27 0.44; 0.08 0.111 myosin VB
Creb 1; 0.05 0.98; 0.22 1 CREB
Bdnfa,b 1; 0.17 0.16; 0.18 0.029 BDNF
CamkII 1; 0.27 1.30; 0.26 0.762 calcium/calmodulin-dependent protein kinase II
Ryr1 1; 0.24 0.93; 0.19 0.762 ryanodine receptor 1
Ryr2 1; 0.16 0.68; 0.06 0.114 ryanodine receptor 2
Ryr3 1; 0.15 0.61; 0.04 0.067 ryanodine receptor 3
Nr2a 1; 0.01 1.01; 0.01 0.914 ionotropic glutamate receptor subunit NR2A
Nr2b 1; 0.07 1.21; 0.10 0.257 ionotropic glutamate receptor subunit NR2B
Pp2b/Caln 1; 0.09 1.09; 0.16 0.914 calcineurin
Kif17a,b 1; 0.08 0.73; 0.03 0.019 kinesin family 17
Stx17 1; 0.14 0.76; 0.05 0.171 syntaxin 17
Kcnk1 1; 0.17 0.76; 0.09 0.257 potassium channel, subfamily K, member 1
Xpo4 1; 0.18 0.93; 0.14 0.905 exportin 4
Csnk2a 1; 0.14 1.01; 0.07 0.686 casein kinase 2, alpha 1 polypeptide
Adrb1 1; 0.06 1.14; 0.11 0.610 adrenergic receptor, beta 1
Pten 1; 0.12 1.18; 0.16 0.352 phosphatase and tensin homolog
Map2k3 1; 0.07 1.14; 0.09 0.476 mitogen-activated protein kinase kinase 3
Uqcr10 1; 0.45 1.94; 0.49 0.171 ubiquinol-cytochrome c reductase, complex III subunitX
Nipsnap1 1; 0.37 1.35; 0.33 0.610 4-nitrophenylphosphatase domain and non-neuronal
SNAP25-like protein homolog 1
The mRNA levels of indicated genes involved in learning and memory were measured in dissected hippocampus frommale mice using real-time PCR
(XBP1f/f: n = 4; XBP1Nes/: n = 5–6). For comparison, values are shown as fold change of gene expression in XBP1Nes/ in relation to the average of
the value obtained in control XBP1f/f. Mean and SEM are presented. p values were obtained with the Mann-Whitney test.
aGenes showing statistically significant differences in expression.
bGenes that contain putative XBP1s binding sites in their proximal 1-kb promoter region. Promoter sequences were analyzed with the TESS program,
using the TRANSFAC and JASPAR matrices.through input-output measurements (Figure 5D; Figures S5A and
S5B). These findings indicate that the cognitive and synaptic
defects observed in XBP1Nes/ animals are highly dependent
on BDNF expression, implying that XBP1 modulates learning
and memory through the regulation of a distinct group of genes,
with a predominant role in the control of BDNF expression.
Xbp1 mRNA Splicing Is Activated by BDNF In Vitro and
In Vivo
BDNF is known to drive its own expression, a relevant process in
memory consolidation (Minichiello, 2009), and to trigger IRE1a
activation in primary neuronal cultures (Hayashi et al., 2007).(G) Xbp1s (left panel) and Bdnf (right panel) mRNA levels were measured by rea
injected with AAV/XBP1s-HA or AAV/MOCK particles. Expression values were no
the AAV/MOCK group (n = 6). Statistical analysis was performed using Student’s
Data are presented as mean and SEM. *p < 0.05; ***p < 0.001; n.s., non-significa
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neuronal cultures exposed to recombinant BDNF, in addition
to neuronal depolarization with extracellular KCl, suggesting
that this UPR branch is engaged by neuronal stimulation (Figures
6A and 6B). We further demonstrated that recombinant BDNF
enhances Xbp1 mRNA splicing in an IRE1a-dependent manner,
as determined by treating neuronal cultures with the IRE1a inhib-
itor STF083010 (Figure 6C). The effect of BDNF on Xbp1 mRNA
splicing occurs in the absence of general UPR activation, since
Bip and Chop were not induced by BDNF treatment (Figure 6D).
We validated these results in vivo by monitoring the levels
of Xbp1s mRNA in the hippocampus of mice injected withl-time PCR in total cDNA obtained from the hippocampus of wild-type mice
rmalized to b-actin mRNA levels and expressed as fold change with respect to
t test.
nt.
ors
Figure 4. XBP1 Binds to the Promoter IV of Bdnf
(A) The indicated region of Bdnf promoter IV was cloned from mouse genomic
DNA into a luciferase reporter plasmid (BDNF-LUC). A schematic represen-
tation of the construct is shown highlighting the presence of a conservedUPRE
B sequence in the proximal promoter region (upper panel; TSS, transcription
starting site). Bottom panel: HEK293 cells were co-transfected with an
expression vector for active XBP1s and the BDNF-LUC reporter construct
(n = 5) or amutated version where the ACTG core sequence in the UPRE Bwas
deleted (DBDNF-LUC) (n = 4). After 48 hr, luciferase activity was measured as
described in Experimental Procedures. Mean and SEM are shown as fold
change compared to control.
(B) ChIP of XBP1 using an anti-XBP1 antibodywas performed in N2A cells after
transfection with an expression vector encoding an HA-tagged version of
XBP1s (XBP1-HA). Binding of XBP1s to the UPRE B region in the Bdnf pro-
moter was assessed by real-time PCR. As positive control, the binding of
XBP1s to the Dgat2 promoter region (a well-known XBP1 target) was
measured. Values represent relative increase compared to the signal obtained
with the control antibody. Mean and SEM of three independent experiments
are shown.
Cell RBDNF-GFP AAV particles (Figure 6E). Then, we determined
whether the training of animals in the contextual fear-condition-
ing test engages the IRE1a pathway. Indeed, the mRNA levels
of Xbp1s were increased in the hippocampus similarly to the
immediate early gene c-Fos (Figure 6F). Importantly, a direct
correlation between Xbp1 mRNA splicing and c-Fos levels was
observed in this experiment (Figure S6). Collectively, these re-
sults suggest that IRE1a activation is a physiological component
of neuronal processes associated with plasticity and learning,
which may contribute to modulate BDNF signaling.
DISCUSSION
Memory is defined as the process bywhich new information is ac-
quired, consolidated, and retrieved by the brain (Alberini, 2009;
Kandel, 2001). Long-term memory occurs when new neural
synapses are established, allowing the information to be remem-
bered for weeks, months, and even years, in a process that
depends on the synthesis of new mRNA and proteins (Costa-
Mattioli et al., 2009). BDNF is a neurotrophin that regulates brain
development, neuroplasticity, and synaptogenesis in the CNS
and peripheral nervous system through binding and activation
of neurotrophin receptors TrkB (tropomyosin receptor kinase B)
and p75NTR, triggering phosphorylation cascades in neurons
that lead either to enhanced survival, differentiation, and plasticity
or to cell death (Park and Poo, 2013; Bekinschtein et al., 2014).
Several studies have established the importance of BDNF
signaling in cognitive functions, with a predominant impact on
learning and memory-related processes (Lu et al., 2008). BDNF
expression levels are dynamically controlled in an activity-depen-
dent fashion during behavioral tasks; however, available studies
on its transcriptional regulation are complex, indicating the use
of alternative promoters according to the inputs received by
the neuron (Hayes et al., 1997; Nakayama et al., 1994). From
the nine different functional promoters that generate splicing
variants, promoter IV is known to mediate the activity-dependent
transcription of Bdnf through binding of a number of transcription
factors, including the calcium-responsive transcription factor
(CaRF) and CREB (Tao et al., 1998, 2002). These transcription
factors bind to calcium-responsive elements on promoter IV
and are activated by disparate signaling pathways that are trig-
gered by membrane depolarization and calcium entry into cells
(Zheng et al., 2012). Despite the relatively thorough molecular
characterization of activity-dependent transcription of BDNF,
the dynamics and mechanisms that fine-tune BDNF expression
during neural development and plasticity are still poorly under-
stood. Here, we provide evidence that XBP1s has a central role
in learning and memory-related processes, primarily by modu-
lating BDNF expression in the hippocampus. XBP1s directly
binds to and transactivates BDNF promoter IV, which contains
an UPRE-like sequence. Our data suggest that the deficits in
memory performance caused by Xbp1 ablation are mostly due(C) Qualitative in vivo ChIP of XBP1 in hippocampal tissue of wild-type mice.
Anti-Histone H3 antibody or rabbit IgG (immunoglobulin G) were used as
positive and negative IP controls, respectively. Input PCR reactions of Bdnf
and Dgat2 promoter regions were performed with 0.1% or 1% of total starting
material.
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Figure 5. Local Expression of BDNF in the Hippocampus of XBP1-Deficient Animals Improves Long-Term Memory
Three-month-old XBP1Nes/ animals were bilaterally injected with serotype 6 AAVs to deliver BDNF-GFP (AAV/BDNF-GFP) or control (AAV/GFP) particles into
the hippocampi.
(A) Left panel: expression of BDNF-GFP or GFP was confirmed using histological analysis with DAPI co-staining. Scale bars, 100 mm. Right panel: results of the
memory flexibility test performed 2 weeks after viral injections are shown as average number of trials to reach criterion in 4 consecutive days (n = 4 per group).
Data were analyzed using Student’s t test.
(B) Learning performance was assessed in XBP1Nes/mice and littermate control (XBP1f/f) animals using the memory flexibility test (pre-injection). The average
number of trials to reach criterion is presented. After training, the same animals were injected with AAV/BDNF-GFP into the hippocampus using bilateral ster-
eotaxis. Fourteen days after injection, animals were re-trained and tested using the memory flexibility test (XBP1f/f, n = 4; and XBP1Nes/, n = 3). Statistical
analysis was performed using Student’s t test.
(C) Electrophysiological recordings of LTP were performed in hippocampal slices from the same groups of mice shown in (B) (n = 20 slices from three XBP1Nes/
mice; 21 slices from three XBP1f/f mice; 22 slices from three XBP1Nes/ AAV/BDNF-GFP mice; 28 slices from four XBP1f/f mice). Statistical analysis was
performed using two-way ANOVA. R.U., relative units.
(D) Basal synaptic transmission recorded in hippocampal slices from animals injected with AAV/BDNF-GFP (n = 26 slices from three XBP1Nes/ mice; 36 slices
from three XBP1f/f mice; 31 slices from 3 XBP1Nes/ AAV/BDNF-GFPmice; 39 slices from four XBP1f/f AAV/BDNF-GFPmice). Statistical analysis was performed
using two-way ANOVA followed by Bonferroni post-test.
Data are presented as mean and SEM. *p < 0.05; ***p < 0.001; n.s., non-significant.
See also Figures S4 and S5.to BDNF deficiency; however, we cannot rule out additional con-
sequences of targeting XBP1 in the nervous system.
Using gain- and loss-of-function approaches, we demon-
strated that XBP1 is required for the optimal establishment of
long-term hippocampus-dependent memories. This unex-
pected function may have an evolutionary origin, since XBP1
is a member of the ATF/CREB superfamily of transcription fac-
tors. Indeed, early studies from our group revealed that XBP1
preferentially binds to and transactivates CRE-like sequences
containing an ACGT core (Clauss et al., 1996). CREB is a key
transcription factor required for long-lasting modulation of syn-1390 Cell Reports 14, 1382–1394, February 16, 2016 ª2016 The Authaptic plasticity and memory (Alberini, 2009). XBP1s may act
in concert with CREB to induce memory formation and may
oppose the repressor activity of ATF4 (Costa-Mattioli et al.,
2005, 2007), another closely related transcription factor impli-
cated in the adaptive response to ER stress (Walter and Ron,
2011). The eIF2a and ATF4 pathway has been associated
with negative control of long-term memory formation due to
its inhibitory activity on protein synthesis andCREB expression,
respectively (Costa-Mattioli et al., 2007, 2009). Even though
we did not observe significant activation of eIF2a phosphory-
lation or upregulation of ATF4 levels in the hippocampus ofors
Figure 6. Regulation of XBP1 mRNA Splicing by BDNF
(A) Xbp1smRNA levels were measured by real-time PCR in cortical neuron primary cultures treated with recombinant BDNF (100 ng/ml) or KCl (15 mM) for 16 hr
(n = 3). Statistical analysis was performed using Student’s t test (***p < 0.001). NT, not treated.
(B) XBP1 mRNA splicing was determined by RT-PCR using a PstI-based assay in mouse hippocampal primary cultures treated with recombinant BDNF
(100 ng/ml) for 16 hr. PCR fragments corresponding to the spliced Xbp1 (Xbp1s) and unspliced Xbp1 (Xbp1u) mRNA are indicated. As control, cultures
were also treated with 10 mg/ml of tunicamycin (Tm). Bands were spliced from the same gel under identical film exposure.
(C) Xbp1smRNA levels were measured by real-time PCR in cortical neuron primary cultures treated with recombinant BDNF in the presence or absence of 50 mM
of an IRE1a pharmacological inhibitor (inh.) (n = 3). Statistical analysis was performed using Student’s t test.
(D) mRNA levels of the ER stress-target genes Bip and Chop were determined in samples shown in (B) using real-time PCR. TM, tunicamycin.
(E) Wild-type mice were injected with AAV/GFP or AAV/GFP-BDNF particles into the hippocampus using brain stereotaxis. Two weeks after injection, Xbp1s
mRNA levels were measured by real-time PCR in total cDNA obtained from dissected hippocampus (n = 3 per group). Expression values were normalized to
b-actin levels. Statistical analysis was performed using Student’s t test.
(F) Xbp1s (left panel) and c-Fos (right panel) mRNA levels were measured by real-time PCR in total cDNA obtained from the hippocampus of wild-type mice after
3 hr of testing in the contextual fear-conditioning assay (CFC). Expression values were normalized to b-actin mRNA levels and expressed as fold change with
respect to naive mice (naive, n = 5; post-test, n = 10). Statistical analysis was performed using Mann-Whitney U test.
(G) Working model: expression of XBP1 in hippocampal neurons directly or indirectly (dotted lines) controls the expression of different genes involved in the
establishment of memory and other cognitive processes. Direct regulation of BDNF expression occurs through the binding of XBP1 to an UPRE B binding site
(legend continued on next page)
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XBP1-deficient animals, the opposing interplay of both path-
ways during neural plasticity needs further elucidation.
XBP1 deficiency in the nervous system did not result in sig-
nificant alterations in the basal levels of canonical UPR-target
gene expression. Instead, our results suggest that XBP1 has
a unique role in the brain under physiological conditions that
is unrelated to its identity as a key ER stress protein. This result
is consistent with recent evidence that XBP1-mediated tran-
scription is context dependent (Cornejo et al., 2013; Hetz
et al., 2015). XBP1s physically interacts with different protein
partners, establishing distinct transcriptional programs. For
example, XBP1s forms heterodimers with other transcription
factors of the same superfamily, such as ATF6f (activating tran-
scription factor 6 fragment), to regulate specific gene expres-
sion patterns (Shoulders et al., 2013), whereas in the liver,
XBP1s specifically controls genes involved in lipid and choles-
terol synthesis (Lee et al., 2008). We also reported that, in the
context of cancer, XBP1s physically interacts with HIF1, driving
the expression of genes involved in angiogenesis (Chen et al.,
2014). Additionally, XBP1 represses the expression of the tran-
scription factor FOXO1, regulating glucose metabolism (Zhou
et al., 2011) and autophagy in a model of Huntington’s disease
(Vidal et al., 2012). Based on this evidence, we speculate that
XBP1s may control the expression of memory-related genes
in the hippocampus through the interaction with specific tran-
scription factors and activity-dependent signaling pathways, a
hypothesis that we are currently investigating through interac-
tome studies.
BDNF signaling has at least two modalities: one leading to
transient phosphorylation of TrkB and short-lived downstream
messaging and a second sustained mode that chronically acti-
vates TrkB phosphorylation and leads to enhanced neurite
branching and structural changes associated with long-term
plasticity (Park and Poo, 2013). One explanation for this dual
dynamics is the self-amplification of BDNF signaling through
an autocrine-positive feedback (Cheng et al., 2011). We specu-
late that the activation of the IRE1a/XBP1 signaling module in
neurons may operate as an amplification loop reinforcing
BDNF signaling to fine-tune synaptic plasticity and learning
and memory-related processes (see model in Figure 6G). We
are currently investigating the downstream signaling events
that engage IRE1a activation by BDNF or electrical stimulation
in neurons, which may occur through posttranslational modifica-
tions of IRE1a as reported in other systems (Hetz et al., 2015).
Our data, together with the discovery of a polymorphism in
the XBP1 promoter associated with bipolar disorder (Kakiuchi
et al., 2003), schizophrenia (Kakiuchi et al., 2004), and Alz-
heimer’s disease (Liu et al., 2013), suggest that alterations in
XBP1 function may lead to the development of serious cognitive
disorders in humans. Strategies to enhance XBP1s activity in
specific areas of the brain, such as gene therapy, may thus trans-
late into beneficial effects in the context of cognitive impairment
associated with prevalent diseases such as Alzheimer’s disease.located in the proximalBdnf promoter region. Behavioral and/or electrical stimulus
and XBP1s expression, in part, through TrkB or p75NTR signaling.
Data are presented as mean and SEM. *p < 0.05; **p < 0.01; ***p < 0.001; n.s., n
See also Figure S6.
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Behavioral Tests
Animal care and experimental protocols were performed according to
procedures approved by theGuide for the Care andUse of Laboratory Animals
(Institute of Laboratory Animal Resources, Commission on Life Sciences, Na-
tional Research Council, 1996), the Institutional Review Board’s Animal Care
and Use Committee of the Harvard School of Public Health (approved animal
protocols 04137 and 04567), the Bioethical Committee of the Faculty of Med-
icine, University of Chile (protocol number CBA0503 FMUCH), and the Bioeth-
ical Committee of the Pontifical Catholic University of Chile.
Behavioral experiments were performed in a blinded fashion, using groups
of age-matched male mice. For contextual and cued fear conditioning: on
the first day,micewere allowed to habituate in the contextual fear-conditioning
chamber (Med Associates) for 5min. After 24 hr, animals were trained for 2min
and then exposed to 80 db of white noise (conditioned stimulus; CS) for 30 s.
After 2 s, mice were exposed to a 0.5-mA electric shock (unconditioned stim-
ulus) that was then repeated five times. On the next day, freezing events were
scored for 5 min without CS in the same chamber (contextual) or with CS in a
different context (cued) using an automated system. For memory flexibility:
mice were trained in a standard Morris water maze for up to 15 trials per day
until they learned the location of the hidden platform. After training, the position
of the platform in the maze was changed daily. The number of trials to criterion
represents the number of trials necessary to learn the new location of the plat-
form each day. The criterion is defined as three consecutive successful trials in
an average of 20 s, without any trial over 30 s.
Electrophysiological Measurements
Transverse slices (350 mm) from the dorsal hippocampus and fEPSPs were
evoked in CA1 with a bipolar cathodic stimulation to Schaffer collateral fibers.
To generate LTP, we used TBS or HFS. TBS consists of four theta epochs with
ten trains of four 100-Hz pulses delivered at 5 Hz. HFS consists of three trains
of 100-Hz pulses, 500 ms each, with an inter-train interval of 20 s. Recordings
were filtered at 2.0–3.0 kHz, sampled at 4.0 kHz using an A/D converter, and
analyzed with pClamp 10 (Molecular Devices).
Biochemical Analysis
Western blot, real-time PCR, and molecular biology assays to address the
impact of XBP1 on gene regulation and BDNF expression were performed us-
ing standard methods.
Statistical Analysis
All data are shown asmean ±SEM. Significance was calculated as indicated in
the figure legends using Student’s t test, Mann-Whitney test, or two-way
ANOVA followed by Bonferroni correction.
Detailedmethods are provided in the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2016.01.028.
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